Laxminarayan Bhat, Ph.D.
Founder and CEO

Laxminarayan Bhat is the Founder and Chief Executive Officer of Reviva Pharmaceuticals, Inc. Dr. Bhat brings over 10 years of drug discovery and development experience in the areas of cancer chemotherapeutics, central nervous system (CNS), cardiovascular (CV), and metabolic diseases. Dr. Bhat has extensive research experience in design and development of prodrugs and softdrugs to improve the ADME-Tox properties of drug molecules. Dr. Bhat has a rich experience in nutrient transporter assisted drug delivery to improve the target selectivity and oral bioavailability of drugs.

Prior to founding Reviva, Dr. Bhat held research positions at XenoPort and ARYx Therapeutics in California. In 1997, Dr. Bhat joined Higuchi Biosciences Center’s Drug Discovery Program at the University of Kansas and there he spent over two years as a Research Fellow. Dr. Bhat received post-doctoral training from the University of Gőttingen in Germany and the University of Maine in France. In 1995, Dr. Bhat was selected for the Alexander von Humboldt fellowship, an internationally recognized prestigious award for a young scientist to pursue advanced research in Germany. Dr. Bhat holds a Ph.D. degree in synthetic organic chemistry. During his scientific career, Dr. Bhat has published 14 research articles in noted peer-reviewed journals. Dr. Bhat is an inventor on over 20 United States and international (PCT) patents.